PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Inventories
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for the quarter ending 2025-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for the quarter ending 2025-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for the quarter ending 2024-09-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for fiscal 2024 was $1.15M, a 175.85% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for fiscal 2023 was $418.47K, a 92.37% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in inventories for fiscal 2022 was $217.53K, a 77.97% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 10-K · filed 2025-09-23 | ||||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 | ||||
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $2.23M derived: sum of 4 quarters · filed 2025-09-23 | ||||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $2.23M derived: sum of 3 quarters · filed 2025-09-23 | $1.15M 10-K · filed 2025-09-23 | -$1.15M 10-K · filed 2024-09-30 | |||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $2.23M derived: sum of 2 quarters · filed 2025-05-14 | $1.15M 10-Q · filed 2025-05-14 | -$1.15M 10-Q · filed 2024-05-15 | $1.26M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $1.15M 10-Q · filed 2025-02-13 | -$1.15M 10-Q · filed 2024-02-14 | $1.26M derived: sum of 3 quarters · filed 2025-02-13 | $1.39M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | -$1.07M 10-Q · filed 2024-11-14 | -$968.22K derived: sum of 2 quarters · filed 2024-11-14 | -$838.98K derived: sum of 3 quarters · filed 2024-11-14 | -$740.28K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $104.03K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $233.27K derived: sum of 2 quarters · filed 2024-09-30 | $331.98K derived: sum of 3 quarters · filed 2024-09-30 | $418.47K 10-K · filed 2024-09-30 | ||||
| 2023-03-31 | $129.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $227.94K derived: sum of 2 quarters · filed 2024-05-15 | $314.44K 10-Q · filed 2024-05-15 | -$314.44K 10-Q · filed 2023-05-15 | $661.98K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $98.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $185.20K 10-Q · filed 2024-02-14 | -$185.20K 10-Q · filed 2023-02-14 | $532.74K derived: sum of 3 quarters · filed 2024-02-14 | $485.84K derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-09-30 | $86.50K 10-Q · filed 2023-11-14 | $434.04K derived: sum of 2 quarters · filed 2023-11-14 | $387.13K derived: sum of 3 quarters · filed 2023-11-14 | $250.09K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $347.54K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $300.63K derived: sum of 2 quarters · filed 2023-09-28 | $163.60K derived: sum of 3 quarters · filed 2023-09-28 | $217.53K 10-K · filed 2023-09-28 | -$217.53K 10-K · filed 2022-09-22 | |||
| 2022-03-31 | -$46.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$183.94K derived: sum of 2 quarters · filed 2023-05-15 | -$130.01K 10-Q · filed 2023-05-15 | $130.01K 10-Q · filed 2022-05-16 | $1.15M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$137.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$83.10K 10-Q · filed 2023-02-14 | $1.20M derived: sum of 3 quarters · filed 2023-02-14 | $690.84K derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $53.93K 10-Q · filed 2022-11-14 | $1.34M derived: sum of 2 quarters · filed 2022-11-14 | $827.88K derived: sum of 3 quarters · filed 2022-11-14 | $1.02M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $773.94K derived: sum of 2 quarters · filed 2022-09-22 | $962.04K derived: sum of 3 quarters · filed 2022-09-22 | $987.24K 10-K · filed 2022-09-22 | ||||
| 2021-03-31 | -$510.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$322.12K derived: sum of 2 quarters · filed 2022-05-16 | -$296.92K 10-Q · filed 2022-05-16 | $296.92K 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | $188.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $213.29K 10-Q · filed 2022-02-14 | ||||||
| 2020-09-30 | $25.20K 10-Q · filed 2021-11-15 | -$25.20K 10-Q · filed 2020-11-16 | ||||||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | |||||
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |